For example, differences in cognitive outcomes in Lewy body diseases (including PD, PDD and DLB), such as timing, severity and pace of decline, have been discussed to not only be explained by the effects of APOE4, but also by other individual factors (Carceles-Cordon et al., 2023). Here, APOE is linked to Lewy body dementia.